Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2010
11/03/2010CN101313948B Xianzi muscle promoting plaster
11/03/2010CN101293068B Method for preparing traditional Chinese medicine for treating qi-blood asthenia type hypogalactia
11/03/2010CN101293014B Medicament for treating acute pyogenic infection of skin
11/03/2010CN101264266B Externally-applied paste for treating gland hyperplasia
11/03/2010CN101264242B Medicaments preparations for treating hemorrhage, pain and dropsy
11/03/2010CN101249235B Chinese medicine for curing esophagus cancer and method of preparing the same
11/03/2010CN101239106B Pharmaceutical formulation with anticancer function
11/03/2010CN101234149B Composition for treating pain of head, face and limbs and various tendons clonic convulsion and preparation thereof
11/03/2010CN101229263B Chinese traditional medicine for treating dermatosises
11/03/2010CN101229195B Traditional Chinese medicine for treating slight burns and scalds
11/03/2010CN101190239B Products containing LP lactic acid bacteria
11/03/2010CN101167871B Compound pearl lozenge and preparation method and application thereof
11/03/2010CN101116692B Medicine for treating hyperplasia of mammary glands
11/03/2010CN101112569B Medicine for removing speckle and the preparation method thereof
11/03/2010CN101095947B Multilevel bionic melissa powder and the method for preparing the same
11/03/2010CN101095933B Chinese traditional medicine compound recipe for healing bones and treating wound
11/03/2010CN101095743B Exterior-applied medicine composition for treating gynecologic diseases and method of making the same and the use thereof
11/03/2010CN101007116B A traditional Chinese medicine for treating diabetes mellitus and complications as a supplementation therapy
11/02/2010US7825093 Methods of using OSK1 peptide analogs
11/02/2010US7824913 Tissue engineering; in vitro method for inducing cells to produce an extracellular matrix; living extracellular matrix, which has tissue-like properties, can be used for testing or clinical purposes
11/02/2010US7824732 Encapsulated chromonic particles
11/02/2010US7824712 Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof
11/02/2010US7824711 comprising osteogenesis enhancing material selected from juvenile cartilage, neocartilage particles or mixtures and biocompatible matrices, used for bone maintenance and regeneration
11/02/2010US7824694 decreasing dose of headache medication (acetaminophen) via titration process in reverse of dosing regimen, locally administering botulin toxin; pharmacokinetics
11/02/2010US7824688 Glucan-based vaccines
11/02/2010US7824686 Vaccines with enhanced immune response and methods for their preparation
11/02/2010US7824671 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
11/02/2010US7824670 Use of il6r/il6 chimera in nerve cell regeneration
11/02/2010CA2534013C Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
11/02/2010CA2467359C Electroprocessed collagen
11/02/2010CA2459690C Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
11/02/2010CA2458740C Method of treating systemic inflammatory response syndrome
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2396698C Tissue graft
11/02/2010CA2336602C Companion animal therapeutic treat
11/02/2010CA2150555C Cloning and expression of biologically active alpha-galactosidase a
10/2010
10/28/2010WO2010123994A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
10/28/2010WO2010123942A2 Materials and methods for using adipose stem cells to treat lung injury and disease
10/28/2010WO2010123243A2 Composition containing a testis extract for treating or preventing diseases
10/28/2010WO2010123200A2 Bacteriophage which kills pathogenic enteric bacteria
10/28/2010WO2010122961A1 Method for preparing cell pharmaceutical
10/28/2010WO2010122945A1 Method for preparing human t cell population having both cytotoxic and immunosuppressive activities
10/28/2010WO2010122787A1 Peritoneum-protecting agent and method for producing peritoneum-protecting agent
10/28/2010WO2010122545A1 Microorganism comprising particles and uses of same
10/28/2010WO2010122378A1 Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6
10/28/2010WO2010121404A1 Bear bile extract and preparation method and use thereof
10/28/2010WO2010091262A8 Chimeric newcastle disease viruses and uses thereof
10/28/2010WO2010083051A9 Cartilage particle tissue mixtures optionally combined with a cancellous construct
10/28/2010WO2010077682A3 Treatment of hiv and aids using probiotic lactobacillus reuteri
10/28/2010WO2010056341A3 Compositions and methods for tissue repair
10/28/2010US20100275282 Methods and systems for identifying immunomodulatory substances
10/28/2010US20100275280 Method for identifying, expanding and removing adult stem cells and cancer stem cells
10/28/2010US20100273996 Method
10/28/2010US20100272839 Treatment of fatty scalp with a lysate of bifidobacterium species
10/28/2010US20100272824 Compositions and methods for preventing and monitoring disease
10/28/2010US20100272816 Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
10/28/2010US20100272812 Rgd-modified alginate microparticles as a drug release system
10/28/2010US20100272803 Repair and regeneration of ocular tissue using postpartum-derived cells
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272786 Vaccine
10/28/2010US20100272776 Device including bone cage and method for treatment of disease in a subject
10/28/2010US20100272761 Synthesis of lipoamide-grafted high molecular compound and method therefor
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272753 Recombinant Adenovirus Vaccines
10/28/2010US20100272746 Lipoparticle comprising a protein and methods of making and using the same
10/28/2010US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
10/28/2010US20100272700 Dendritic cell precursors
10/28/2010US20100272697 Pancreatic islet cells composition and methods
10/28/2010US20100272696 Human Bone-Forming Cells In The Treatment of Inflammatory Rheumatic Diseases
10/28/2010US20100272695 Cell compositions derived from dedifferentiated reprogrammed cells
10/28/2010US20100272694 Clinic compliant method for banking human placental mesenchymal cells
10/28/2010US20100272692 Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium
10/28/2010US20100272691 Viruses
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/28/2010US20100272687 Mutant viruses and uses thereof
10/28/2010US20100272686 Oncolytic virus
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/28/2010US20100272684 Hyperbaric treatment in wound healing
10/28/2010CA2759244A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
10/28/2010CA2756340A1 Bear bile extract and preparation method and use thereof
10/28/2010CA2741965A1 Microorganism comprising particles and uses of same
10/27/2010EP2243826A2 Mesenchymal stem cells and uses therefor
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2243487A1 Enteric coated formulation
10/27/2010EP2242839A2 Methods of obtaining antigen-specific t cell populations
10/27/2010EP2242508A2 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations
10/27/2010EP1894995B1 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN1889853B Anti-diarrhea composition containing glutamine
10/27/2010CN1684672B Dosage form having an inner core and at least two coating layers
10/27/2010CN1380902B Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
10/27/2010CN101873862A Composition and therapeutic anti-tumour vaccine
10/27/2010CN101870943A Brewing method and medicinal effect for special bamboo charcoal purification russula health wine
10/27/2010CN101869700A Chinese medicinal oral liquid for treating tumour and preparation method thereof
10/27/2010CN101869698A Liniment with combination of Chinese medicine and western medicine for fire treatment and preparation method thereof
10/27/2010CN101869696A Method for preparing plaster for treating rheumatic bone diseases
10/27/2010CN101869691A Chinese medicinal composition for treating dysmenorrhea and preparation method thereof
10/27/2010CN101869688A Chinese medicinal compound preparation for treating uterine myoma
10/27/2010CN101869686A Chinese medicinal composition for treating cirrhosis and preparation method thereof
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 1259